CorePharma announced the launch of Dextroamphetamine Sulfate Tablets, the generic version of Shire’s Dextrostat.

Dextrostat is a Class II amphetamine indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. Amphetamines are non-catecholamine, sympathomimetic amines with CNS stimulant activity. Peripheral actions include elevations of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action.

RELATED: ADHD Rx Linked to Lower Smoking Rates

Dextroamphetamine Sulfate is available in 5mg and 10mg strength tablets. CorePharma has begun shipping the product.

Continue Reading

For more information call (800) 850-2719 or visit